Qasim Khan, MBBS, MS, FRCPC
@mqkMD
Transplant Hepatologist @westernuGI| MASH, MetALD, PTMS | @MayoClinicGIHep @Columbia Alum|@humasaeedulhaq's Husband|Girl Dad👨👩👧👧 | Musician🎸🎤| 🇨🇦🇵🇰
👀 Check out our review on 'Specific Etiology' Steatohepatitis, available online via @HEP_Journal. 🙏🙏 Grateful to my amazing mentor @kymwatt and all-🌟colleagues @SaraHassanMD, @MamathaBhat3, and @Blankmd22 for this collab! #livertwitter @AASLDtweets journals.lww.com/hep/abstract/9…
🧬New 📋 @AjmeraVeeral @JHepatology: In MASLD, inherited genetic risk drives age-associated fibrosis. ⬆️ LSMs after 40y in high-risk genotypes 🧪 PNPLA3 genotyping may improve risk stratification 📈 Supports personalized medicine 🔗 doi.org/10.1016/j.jhep… @DrLoomba @UCSD_GI
Wake up, New cause of elevated liver enzymes just dropped
The FIB-4 and Fibroscan are the backbone of noninvasive fibrosis assessment in MASLD, but they're far from perfect! Here, we review novel noninvasive tests and how you can incorporate them into daily practice. #livertwitter @RichSterlingMD @VCU_Liver cghjournal.org/article/S1542-…
Honoured to be in this 🇨🇦 work in @AmJGastro w/ @mayurbrahmania @juanpabloarab and colleagues - Distance from LTx center 🚫 affect post-listing 🪦 or organ receipt. BUT, hospital🛌 and ER🏥 utilization ⬆️ in farther patients PRE-listing. #Livertwitter journals.lww.com/ajg/abstract/9…
#MASLD➡️Not just Western and not just in adults. Scary data for our future unless we act now! @AmCollegeGastro @NASH_and_coffee @GlobalLiver @juanpabloarab
Longitudinal Associations Between Metabolic Dysfunction-Associated Steatotic Liver Disease and Subclinical Cardiovascular Measures in Chinese Children Qiao, et al. 📕 bit.ly/4eb7MBX @MLongMD @JasmohanBajaj @JazzminZheng
Don’t miss @kymwatt, as she breaks down key findings from the #HEPATOLOGY article: “Determining a Safe Washout Period for Immune Checkpoint Inhibitors Prior to Liver Transplantation.” #LiverX youtube.com/watch?v=-9D0Bm…
Pharmacological Strategies for the Management of Severe Alcohol-associated Hepatitis: A Systematic Review and Meta-analysis - Still much work to do in this field- @AGA_CGH cghjournal.org/article/S1542-…
Interdisciplinary perspectives on the co-management of MASLD and coronary artery disease. Last chance for free download (author link expires 1/30/25). @brennap9 @JVLazarus @juanpabloarab @KrittanawongMD @LancetGastroHep #MASLD #MASH kwnsfk27.r.eu-west-1.awstrack.me/L0/https:%2F%2…
📑 Comparative effectiveness of different #corticosteroid regimens in severe #alcohol-associated hepatitis‼️ ❌ difference in 30-day ☠️ between prednisolone, prednisone, or methylprednisolone journals.lww.com/hepcomm/fullte…
🦷🦠New insights on the oral-gut-liver axis! 📖Prof. Juan Pablo Arab and international teams systematically reviewed the bidirectional links between periodontal disease and cirrhosis. Findings: 🔹 Oral dysbiosis may worsen liver disease via the oral–gut–liver axis 🔹…
@juanpabloarab
Over 400 million people globally are affected by alcohol use disorder. In @LancetGastroHep, a recent Review explores the current management and treatment options for alcohol use disorder from a gastroenterology and hepatology-focused perspective: hubs.li/Q03gKvvB0
📢 New in eGastroenterology! 📰 Prof. Juan Pablo Arab, from Virginia Commonwealth University, and collaborators across global centers share important insights in their latest work: Pentoxifylline use in alcohol-associated hepatitis with acute kidney injury does not improve…
What public health measures are effective in decreasing the burden of alcohol-related liver disease ? What new measures should be implemented ? We explain it all in this new article in @NatRevGastroHep
🎁Christmas & New Year's presents from @JHEP_Reports 3 excellent reviews: 🎄Lipid metabolism in MASLD and MASH doi.org/10.1016/j.jhep… 🤶Use of AI for liver diseases doi.org/10.1016/j.jhep… 🎇Mechanisms and implications of recompensation doi.org/10.1016/j.jhep…
New research - Pre-emptive TIPS for gastric variceal bleeding in patients with cirrhosis (GAVAPROSEC): an open-label randomised clinical trial thelancet.com/journals/langa… #LiverTwitter #MedTwitter
🆕CPG in press❕ EASL Clinical Practice Guidelines on the management of extrahepatic cholangiocarcinoma Find it here👉bit.ly/4iTmgqI @EASLnews @EASLedu
Thanks to @CIHR_IRSC for supporting our national project to develop novel AI tools for improved equity and outcomes along the liver transplant patient journey! With Co-PIs @Jenn_Flemming #DivyaSharma @EnglishEdition @rahulgk with support of @CNTRP @UHNTransplant @PSCPartnersCa
(1/2) 🎉 Congratulations to Dr. @MamathaBhat3 @TGHRI_UHN, who leads a project that received close to $2M from @CIHR_IRSC to improve equity in liver transplants using #AI.
📢 It’s OVER. The “lean MASLD paradox”? Just bad measurement. ❎MASLD with overweight BMI weren’t healthier! We were using the wrong metric. ↗️Waist circumference-related indices show a dose-dependent mortality risk across 3 prospective cohorts. Let’s reframe how we assess…
Original Article: Tirzepatide as Compared with Semaglutide for the Treatment of Obesity (SURMOUNT-5 phase 3b trial) nej.md/44ZeMPz @EASOobesity | #ECO2025
Tirzepatide as Compared with Semaglutide for the Treatment of Obesity: @NEJM 🥸 SURMOUNT-5 Trial: Wow! 😱 Summary 👇👇👇